Epic Chain vs Mira — how do they compare? Epic Chain trades at Rp6,607 (market cap Rp218,32M, Rp196,53M 24h volume), while Mira trades at Rp696.68 (market cap Rp224,75M, Rp102,62M 24h volume). The key difference: Epic Chain and Mira are close in size by market cap, and Epic Chain's circulating supply is 33,6M / 33,6M EPIC (100%) versus 321,5M / 1B MIRA (33%) for Mira. Which is the better fit depends on your goals — on Pluang, investors hold Epic Chain for 9 Days and Mira for 22 Days on average.
| EPIC | MIRA | |
|---|---|---|
Market Cap | Rp218,32M | Rp224,75M |
Volume (24h) | Rp196,53M | Rp102,62M |
Circulating Supply | 33,6M / 33,6M EPIC (100%) | 321,5M / 1B MIRA (33%) |
Typical Hold Time | 9 Days | 22 Days |
Signals from Pluang's Aura AI — not financial advice
Epic Chain is currently trading at Rp6,378 with a market cap of Rp214.16M, showing bearish technical signals with moving averages indicating strong selling pressure. The token has 100% circulating supply with relatively short 9-day hold time. Current price sits between support at Rp6,004 and resistance at Rp6,315, with RSI_6 at 25.71 suggesting potential oversold conditions. No recent protocol updates or ecosystem developments were identified.
Overall outlook remains cautious with bearish technical dominance. Key opportunity lies in potential oversold bounce from current levels, while major risks include low liquidity and limited market depth. Investors should monitor for any protocol developments that could drive adoption.
MIRA token trades at Rp724 with bearish technical signals as moving averages indicate strong selling pressure. The token shows neutral oscillators but faces resistance at Rp726-758 levels. With 33% circulating supply and 22-day average hold time, market participation remains limited. Recent ecosystem developments show progress in pharmaceutical research applications, though direct token utility updates are scarce.
Overall outlook remains cautious due to technical bearishness and limited trading volume. Key opportunity lies in potential protocol adoption from pharmaceutical research partnerships. Major risks include low liquidity, high volatility, and regulatory uncertainty surrounding crypto-pharma intersections. Investors should monitor exchange listings and token utility expansion.
What Pluang investors did over the last 30 days
Epic Chain (EPIC), the successor to Ethernity Chain (ERN), was approved by 97.1% of the community and now operates as an ETH Layer 2 blockchain. Focused on Real World Assets (RWAs) and entertainment, it integrates AI-driven security, DRM, and Web3 technology. With the entertainment market set to hit $3.5 trillion by 2030, Epic Chain enables global brands to bring franchises on-chain, already featuring icons like Messi, Shaq, and Muhammad Ali. Now, it expands into top entertainment franchises with improved scalability, security, and efficiency.
Read more on EPIC →Mira is a decentralized verification network that enables autonomous AI by eliminating human oversight. Using consensus-based verification across multiple AI models, Mira delivers mathematically verifiable and trustless results in real time. This ensures accuracy and reliability for critical fields like healthcare, finance, and law—transforming AI from a supervised tool into truly independent intelligence.
Read more on MIRA →